IGC Pharma, Inc. Balance Sheet
IGC|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
IGC Pharma, Inc. had $9M in total assets and $6M in shareholders' equity as of FY2025. Total debt was $134,000 against $405,000 in cash, resulting in a $271,000 net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $405.0K | $1.2M | $3.2M | $10.5M | $7.3M | $25.6M | $1.7M | $538.0K | $1.5M | $824.5K | $1.0M | $1.1M | $562.9K | $1.6M | $1.6M |
| Accounts Receivable | $34.0K | $39.0K | $107.0K | $125.0K | $175.0K | $133.0K | $84.0K | $557.8K | $752.9K | $962.7K | $993.3K | $566.3K | $1.1M | $1.6M | $1.6M |
| Inventory | $1.4M | $1.5M | $2.7M | $3.5M | $5.5M | $4.2M | $248.0K | $486.5K | $0 | $162.1K | $709.6K | $611.7K | $407.1K | $387.5K | $387.5K |
| Current Assets | $2.9M | $3.7M | $6.5M | $15.1M | $23.5M | $17.8M | $26.7M | $3.2M | $3.6M | $3.8M | $4.5M | $3.8M | $4.3M | $5.2M | $5.2M |
| PP&E (Net) | $3.2M | $3.7M | $8.2M | $9.4M | $10.8M | $9.8M | $5.9M | $6.2M | $953.9K | $7.1M | $7.8M | $7.6M | $8.2M | $8.5M | $8.5M |
| Goodwill | - | - | - | - | - | - | - | - | $198.2K | $1.2M | $982.8K | - | - | - | $410.5K |
| Total Assets | $8.7M | $9.9M | $17.2M | $26.8M | $35.9M | $29.0M | $34.5M | $10.9M | $11.3M | $18.9M | $20.3M | $17.7M | $19.3M | $25.3M | $25.3M |
| Current Liabilities | $2.3M | $2.3M | $1.9M | $2.4M | $2.4M | $1.9M | $878.0K | $2.3M | $1.3M | $3.2M | $2.4M | $1.0M | $1.8M | $4.5M | $4.5M |
| Total Debt | $134.0K | $137.0K | $141.0K | $144.0K | $276.0K | - | - | - | $452.1K | $801.5K | $323.9K | - | - | - | - |
| Shareholders' Equity | $6.3M | $14.9M | $23.9M | $32.8M | $26.5M | $33.6M | $8.1M | $8.1M | $7.4M | $13.5M | $14.2M | $13.6M | $14.4M | $14.8M | $14.8M |